Skip to main content
. Author manuscript; available in PMC: 2019 Jun 13.
Published in final edited form as: Eur J Pharmacol. 2017 Aug 26;814:196–206. doi: 10.1016/j.ejphar.2017.08.029

Figure 6.

Figure 6.

Effects of anatabine and myosmine on locomotor activity during each conditioning session. Data from adults are shown in panels A-B, and data from adolescents are shown in panels C-D (n=10/group). * indicates a significant difference from the saline group (dose × session interaction), and # indicates a significant difference from the first session for the same dose group (dose × session interaction). $ indicates a significant main effect of dose or session as shown in the legend and x axis, respectively. Numbers in parenthesis highlight doses with significant effects.